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Abstract: Ubiquinones (UQ) are intrinsic lipid components of many membranes. Besides their role in
electron-transfer reactions there is evidence for them acting as free radical scavengers, yet their other
roles in biological systems have received little study. The dimorphic fungal pathogen Candida albicans
secretes farnesol as both a virulence factor and a quorum-sensing molecule. Thus, we were intrigued
by the presence of UQ9 isoprenologue in farnesol-producing Candida species while other members
of this genera harbor UQ7 as their major electron carrier. We examined the effect of UQ side chain
length in Saccharomyces cerevisiae and C. albicans with a view towards identifying the mechanisms
by which C. albicans protects itself from the high levels of farnesol it secretes, levels that are toxic to
many other fungi including S. cerevisiae. In this study, we identify UQ9 as the major UQ isoprenoid in
C. albicans, regardless of growth conditions or cell morphology. A S. cerevisiae model yeast engineered
to make UQ9 instead of UQ6 was 4–5 times more resistant to exogenous farnesol than the parent yeast
and this resistance was accompanied by greatly reduced reactive oxygen species (ROS) production.
The resistance provided by UQ9 is specific for farnesol in that it does not increase resistance to high salt
(1M NaCl) or other oxidants (5 mM H2O2 or 1 mM menadione). Additionally, the protection provided
by UQ9 appears to be structural rather than transcriptional; UQ9 does not alter key transcriptional
responses to farnesol stress. Here, we propose a model in which the longer UQ side chains are
more firmly embedded in the mitochondrial membrane making them harder to pry out, so that
in the presence of farnesol they remain functional without producing excess ROS. C. albicans and
Candida dubliniensis evolved to use UQ9 rather than UQ7 as in other Candida species or UQ6 as
in S. cerevisiae. This adaptive mechanism highlights the significance of UQ side chains in farnesol
production and resistance quite apart from being an electron carrier in the respiratory chain.
Keywords: farnesol resistance; ubiquinone side chain; yeasts; oxidative stress
1. Introduction
Candida albicans, a member of normal human flora has become the most common nosocomial fungal
pathogen in humans [1]. This yeast shows remarkable diversity in its morphology and secretes farnesol,
a quorum-sensing molecule which mediates yeast to hyphae dimorphism in a cell density-dependent
manner without influencing growth rate [2]. Farnesol is a 15-carbon sesquiterpene which is formed
from farnesyl pyrophosphate, an intermediate in the ergosterol biosynthetic pathway [3]. In vivo, this
lipophilic molecule acts as a virulence factor which enhances systemic candidiasis in mice [4] and stimulates
immune recognition by host macrophages [5]. Farnesol stimulated an 8.5-fold increase in macrophage
migration in vitro and a 3-fold increase of peritoneal infiltration by mouse macrophages in vivo [5].
Wild type C. albicans tolerates up to 300–500 µM farnesol [3,6] while farnesol production can vary
Microorganisms 2020, 8, 1641; doi:10.3390/microorganisms8111641 www.mdpi.com/journal/microorganisms
Microorganisms 2020, 8, 1641 2 of 16
from 0.5 µM to 50 µM, depending on strain differences as well as planktonic or biofilm growth [2,7–9].
The ability of C. albicans to tolerate such high concentrations of farnesol is remarkable because
much lower concentrations of farnesol (<20–25 µM) are antimicrobial towards other microorganisms
including both bacteria and fungi. The growth of S. cerevisiae, a distant cousin of C. albicans, is inhibited
by <25 µM farnesol which causes cell cycle arrest and/or mitochondrial dysfunction [10,11]. Farnesol
can also induce apoptotic cell death in filamentous fungi such as Aspergillus nidulans and Aspergillus
fumigatus [12] as well as Fusarium graminearum [13]. Farnesol also induces reactive oxygen inside
macrophages leading to increased intracellular oxidative stress [14]. The juxtaposition of these
observations poses the question of the mechanisms whereby C. albicans tolerates farnesol doses that
are lethal to other fungi; what adaptations has it made to be able to use farnesol as a quorum-sensing
molecule and a virulence factor?
Current best evidence is that farnesol kills cells by generating superoxide radicals, the major
reactive oxygen species (ROS), by interacting with the mitochondrial electron transport chain during
respiratory growth of S. cerevisiae [10,12,15]. ROS production is a normal byproduct of respiration
and mitochondria have their own antioxidant mechanisms for the efficient elimination of superoxide
anions [16] which can be localized either in the mitochondrial matrix, inner membrane/outer side, outer
membrane/inner side, or intermembrane space [16]. Presumably farnesol enhances ROS production to
a level such that the cell can no longer cope.
Thus, it is reasonable to speculate that a cell or organism could increase its farnesol tolerance by
structural adaptations to mitochondrial membranes or other components in order to avoid leakage of
electrons, thus minimizing cell damage and/or reduced proton motive force.
One of the major sites responsible for electron leakage in the mitochondrial electron transport
chain is ubiquinone, especially when electrons translocate to complex III via reduction of ubiquinone to
ubiquinol [15,16]. Ubiquinones (UQ) are critical membrane-localized electron carriers, which ‘ubiquitously’
exist in the mitochondrial electron transport chain in all living organisms. They are involved in the transfer
of electrons from NADH-ubiquinone oxidoreductase (complex I) and succinate-ubiquinone reductase
(complex II) to ubiquinol-cytochrome c oxidoreductase (complex III) [15,16]. They have a redox active
benzoquinone ring attached to a lipophilic side chain consisting of a variable number of isoprene units
(Figure 1). The number of isoprenoid units varies among species, ranging from 4 to 14, where the number
of isoprenoid units is numerically designated following the abbreviation UQ or Q for ubiquinone.
The hydrophobic isoprene tail is derived from successive head-to-tail condensations of isoprene units
[isoprenyl diphosphate (IPP)] catalyzed by prenyl diphosphate synthase [17]. The specificity of this
enzyme determines the number of isoprenoid units present (i.e., side chain length) and, therefore, it is
believed that the isoform of this enzyme varies among different species [17,18]. Polyprenyl diphosphate
synthase is encoded by a single gene COQ1 in both S. cerevisiae [19] and C. albicans [20] while its homolog
in Arabidopsis thaliana is identified as At2g34630 [21].
The variability of ubiquinone side chain length is often taxonomically useful [22] but functional
differences due to differing UQ side chain lengths have rarely been reported. Thus, we were intrigued
by taxonomic studies which showed that S. cerevisiae produces UQ6 while most Candida species produce
UQ7 except for C. albicans and C. dubliniensis which have UQ9 [23,24]. Significantly, C. albicans and
C. dubliniensis are major human fungal pathogens which cause life-threatening systemic infections in
humans and they are the only two species in the Candida clade known to excrete large quantities of
farnesol [8,9]. As would be expected for organisms using farnesol in this fashion, the growth rates
of C. albicans and C. dubliniensis were not affected by 300 µM [2,6] and 150–200 µM [25,26] farnesol,
respectively. These observations led us to hypothesize that a longer isoprenoid chain length may
provide an advantage to farnesol-producing Candida species, allowing them to cope with the oxidative
stress exerted by the ROS generated by farnesol. In this study, we tested this hypothesis by comparing
the farnesol sensitivity of yeasts, using a recombinant S. cerevisiae which produces UQ9 instead of
UQ6 [21]. Our findings suggest that a longer isoprenoid side chain length protects yeasts from farnesol
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and excess ROS by a mechanism independent of transcriptional regulation. Thus, synthesizing UQ9
instead of UQ7 could serve as a pathogen-adapted structural trait in C. albicans.Microorganisms 2020, 8, x FOR PEER REVIEW 3 of 17 
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Figure 1. Structures of ubiquinones and farnesol. Ubiquinone consists of a benzoquinone ring (aromatic
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chain (UQ6), while most Candida sp. have seven (UQ7), and C. albicans has nine (UQ9). Farnesol,
is a C15 sesquiterpene alcohol with only three isoprenoid units.
2. Materials and Method
2.1. Yeast Strains an Media
The yeast strains used in this study are listed in Table 1. C. albicans SC5314 and WO-1 were obtained
from Alexander Johnson, University of California at San Francisco, and David Soll, University of Iowa,
respectively. S. cerevisiae BY4741 and its isogenic mutants, ∆coq1::pYES, ∆coq1::pYES + At2g34630,
and ∆coq1::pYES + COQ1 were obtained from Gilles Basset, University of Nebraska-Lincoln [21].
The ∆coq1::pYES was effectively a petite strain in that it was unable to grow on glycerol + ethanol agar
plates [21]. The expression capacity of the pYES system was ca. 60% of the BY4741 parent, with pYES +
COQ1 producing UQ ≤6 and pYES + At2g34630 producing UQ 7–9 [21].
Yeast extract-peptone-dextrose (YPD) medium containing 1% yeast extract, 1% peptone, and 2%
glucose was used for routine growth of yeast stock cultures and in farnesol sensitivity assays. YPD was
supplemented with 0.05% (w/v) D-galactose as an inducer for all S. cerevisiae strains, and G418 (Geneticin
purchased from Gold Biotechnonlgy, St. Louis, MO, USA, 200 µg/mL) as the selective antibiotic for
strains constituted with plasmid vector unless specifically mentioned. The glucose-salts-biotin (GSB)
medium contained 1 g/L of (NH4)2SO4, 2 g/L of KH2PO4, 50 mg/L of MgSO4.7H2O, 50 mg/L of
CaCl2.2H2O supplemented with sterile 30 mL of a 50% (wt/vol) glucose stock and 0.4 mL of the
vitamin stock (containing 0.002% biotin, 0.02% pyridoxine and 0.02% thiamine in 20% ethanol) [2].
GSB was used as a minimal medium for preparing C. albicans cell stocks for inoculum preparation
and ubiquinone analysis. Modified glucose-proline-phosphate (GPP) medium [27] was used for
preparation of anaerobic cells from C. albicans SC5314. Synthetic complete (SC) medium used to grow
opaque cells from C. albicans SC5314 was composed with 0.67% yeast nitrogen base, 2% glucose and
supplemented with appropriate amino acids [28].
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Table 1. Strains used in this study.
Yeast Strains Genotype Description Source UQ
C. albicans strains
SC5314 Wild type (clinical isolate) [29] UQ9
WO-1 MTLa frequent white/opaque switching [30] UQ9
S. cerevisiae strains
BY4741 parent BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 rho+ [21] UQ6
∆coq1::pYES coq1 knockout transformed with empty vector [21] none
∆coq1::pYES + At2g34630 coq1 knockout transformed with Arabidopsis At2g34630 [21] UQ9
∆coq1::pYES + COQ1 coq1 knockout transformed native COQ1 gene [21] UQ6
2.2. Inoculum Preparation
Inocula were grown from single colonies of C. albicans SC5314 and WO-1 in YPD at 30 ◦C for
16–18 h with shaking at 225 rpm. The stationary phase cells were harvested by centrifugation at
5000 rpm in Beckman J-21C centrifuge and washed three times in 50 mM potassium phosphate buffer
(pH 6.5). These cells were inoculated into minimal media (GSB) and grown at 30 ◦C in a shaking
incubator at 225 rpm until they reached a stationary phase whereupon they were harvested and
washed as described above and then stored at 4 ◦C. The cells were used within a week of preparation.
The C. albicans WO-1 opaque cells were grown in SC medium to stationary phase whereupon the cells
were harvested and stored at 4 ◦C as described above.
2.3. Ubiquinone Analysis in C. albicans
To analyze ubiquinone content in C. albicans, the cells were grown in 40 mL of either rich (YPD) or
minimal media (GSB, GPP with N-acetylglucosamine, or SC) at 30 or 37 ◦C for 18–24 h as appropriate
to induce the different morphological stages of C. albicans, i.e., yeasts or mycelia, white or opaque
cells, or anaerobically grown cells. The morphology of each cell type was confirmed by microscopy
before harvesting. Cells were harvested by centrifugation at mid-exponential phase, washed once
with 25 mL of water, and resuspended in 1 mL of water whereupon cell number was quantified by
absorbance at 600 nm and the cell numbers normalized by adjusting the volume of each sample.
One ml of each suspension was transferred to a 10mL pyrex tube containing 0.5 mL of 0.5 mm glass
beads, spiked with 8.5 nmoles of UQ-10, and vortexed for 90 s. Samples were then mixed with
2 mL of 95% ethanol, heated at 70 ◦C for 10 min, cooled and extracted twice with 5 mL hexane.
The hexane layers were combined, evaporated to dryness with N2, and resuspended in 1 mL of
methanol: dichloromethane (10:1). The types of UQ present in the ubiquinone pool were identified as
described by Ducluzeau et al. [21] using high-performance liquid chromatography (HPLC) in diode
array detection (DAD) mode with UQ10 as the internal standard [21]. Extracts from cell suspensions
were analyzed at 30 ◦C by HPLC (Agilent, Santa Clara, CA, USA) on a 5 µM Supelco Discovery C-18
column (250 × 4.6 mm, Sigma-Aldrich, St. Louis, MO, USA) in isocratic mode at a flow rate of 1 mL
min−1 with methanol:hexane (95:5 v/v) for spectrophotometric detection of quinones at 275 nm. Quinol
species had been fully reoxidized during heating and were quantified as a part of the quinone pool.
Retention times for the ubiquinones were 8.6 min for UQ-6, 11.5 min for UQ-7, 15.8 min for UQ-8,
22.1 min for UQ-9, and 31.5 min for UQ-10. The typical recovery value for yeast ubiquinones is
approximately 90% and data were corrected accordingly. All glassware used for culture growth and
analysis were washed with 2M NaOH and then rinsed with Milli-Q water followed by a final rinse
in acetone.
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2.4. Farnesol Sensitivity Assays—High Aeration
Stock cells were prepared as described above and used at an initial OD600 = 0.02 (6 × 105 cells/mL).
These cells were tested for their sensitivity to farnesol via a series of growth curves and live dead
cell assays at different farnesol concentrations (0, 50, and 100 µM farnesol in methanol) where the
final methanol concentration never exceeded 1%, a concentration that had no effect on cell growth or
death [2]. Growth studies were undertaken with 50 mL YPD or GSB in 250 mL glass Erlenmeyer flasks
with rotary agitation at 225 rpm, measuring optical density at 600 nm in a Spectra MaxPlus Microplate
Spectrophotometer. Cell death was followed by staining the yeast cultures with 0.05% methylene blue
at specified time points. For all experiments, farnesol was present from time zero and the 0 farnesol
samples still contained methanol, thus serving as methanol-only controls which did not inhibit growth
or promote cell death.
2.5. Farnesol Sensitivity Assays—Low Aeration
Fresh single colony isolates were grown overnight at 30 ◦C in 4 mL of YPD supplemented with
G418 (200 µg/mL) for selection and D-galactose (0.05% w/v) for induction. Cultures were tested for
their farnesol sensitivity in sterile Corning costar 96-well flat bottom plates with low evaporation lids.
The overnight cultures were diluted to OD600 = 0.1 with YPD + D-galactose. Each well contained
200 µL of culture and farnesol (0, 50, 100, 200, or 400 µM) in four replicates. The farnesol stock
solution was 400 mM in methanol so that after dilution each culture had ≤0.1% methanol. Growth
assays were performed at 30 ◦C in a Biotek Synergy H1 Hybrid Reader using Gen5 Microplate reader
software v2.0.01.14. Plates were oscillated for one minute every 10 min before the OD600 was recorded.
The growth data was exported as Microsoft excel spreadsheet files and assessed with Sigma Plot 12.
2.6. Measurement of Intracellular Reactive Oxygen Species (ROS) via DHR123 Staining
Synchronized yeast cells were obtained by diluting an overnight culture of stationary phase cells
in YPD liquid media to 0.1 OD600 and incubating it at 30 ◦C with shaking until it reached 0.5 OD600.
These mid-log cells were subdivided into flasks and then treated with 0–400 µM farnesol or 10 mM
hydrogen peroxide as the positive control. After 4 h shaking, 1 mL samples from each flask were
dispersed into 5 mL polystyrene round bottom tubes (BD Biosciences No. 352058) and immediately
stained for ROS with 1 µg/mL Dihydrorhodamine 123 (DHR123, Sigma Aldrich D1054, St. Louis, MO,
USA) in dimethylsulfoxide and incubated at 37 ◦C for 30 min in the dark. The fluorescent intensity of
the cells was analyzed immediately by a BD® FACSCantor flow cytometer using triplicate samples.
Data are presented as the fold change, i.e., the ratio of the fluorescence/basal fluorescence with no
farnesol or H2O2. In this procedure, the freely permeable, non-fluorescent DHR123 enters the cells
where it is oxidized by ROS in the cytoplasm, resulting in formation of the fluorescent dye which is
then localized in the mitochondria [31].
2.7. Measurement of Oxygen Consumption Rate in Yeasts
Cells (25 mL) were grown aerobically to mid logarithmic phase with rotary agitation at 225 rpm,
harvested, washed twice in YEP medium [1% yeast extract, 1% peptone and 0.5% sodium chloride
(pH 7.0)] and resuspended in 700 µL of the same medium. Glucose was added to each sample to
a final concentration of 2% right before analysis and oxygen consumption was monitored using a
Clark-type oxygen electrode (Rank Brothers, Cambridge, UK) until all oxygen in the sample chamber
was consumed. Calibration of the Clark electrode for maximum oxygen consumption was done
under normal atmospheric conditions and the slope was calculated for each sample when oxygen
consumption was linear. The rate of respiration was normalized to the cell number in the chamber
(OD 600 nm) and expressed as % O2/min/OD600. The values reported were the means ± standard
deviation (SD) of three or four replicates.
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2.8. Salt and Oxidative Stress Assays
The yeast strains to be tested were grown in liquid YPD culture to mid-log phase and then spotted
onto YPD + 0.05% galactose agar plates with and without the salt or oxidant being tested, with inocula
at a series of 10-fold dilutions. Plates were photographed after 48 h at 30 ◦C.
2.9. Catalase Activity Induced by Sub-Lethal (20 µM) Farnesol
Yeast cells were grown to exponential phase in rich media (YPD) and exposed to sub-lethal
concentrations of farnesol (20 µM) for 60 min. The cells were harvested just after farnesol treatment
and catalase activity was determined by a colorimetric assay using the EnzyChrom catalase assay kit
(BioAssay Systems, Hayward, CA, USA) according to the manufacturer’s instructions. The test was
performed in three biological replicates and results were analyzed using the Student t-test at p < 0.05.
3. Results
3.1. UQ9 is the Major Ubiquinone in C. albicans
The diversity of ubiquinone presence in genus Candida was studied in detail by Suzuki and
Nakase [23,24] where UQ9 was identified as the major ubiquinone in C. albicans strain JCM 1542
(IFO 1385). Ubiquinones are known to be localized in different types of cell membranes. Due to the
distinct structural and chemical compositions in different morphologies of C. albicans, we analyzed the
ubiquinone pool in C. albicans cells grown under different physiological conditions and/or in different
morphological states, i.e., yeasts, hyphae, anaerobically grown cells, and both white and opaque
cells (Figure 2). We confirmed that UQ9 is the major type of UQ in C. albicans in two widely used
laboratory strains SC5314 and WO-1 (Table 1) as analyzed by HPLC-DAD with UQ10 as the internal
standard [21]. Figure 2a shows the retention profile of ubiquinones in wild type C. albicans grown in
minimal media and Figure 2b summarizes the ubiquinone types and total ubiquinone content under
different physiological and morphological states. These data confirm the predominance of UQ9 in all
cell types except for the anaerobically grown cells which lack detectable ubiquinones. In particular, UQ9
was the dominant ubiquinone in both rich medium (YPD) and minimal medium (GSB), for both white
cells and opaque cells, and for both mycelial cells (37 ◦C) and yeast cells (30 ◦C). These observations
show that UQ9 is a general characteristic of C. albicans regardless of the cell morphology. We did not
detect any UQs in anaerobically grown cells; this absence is expected because mitochondrial respiration
is absent in anaerobically growing cells.
3.2. Farnesol Resistance in S. cerevisiae Depends on the UQ Isoprenologue, UQ6 vs. UQ9
The importance of ubiquinone chain length for farnesol resistance was tested by comparing
strains of S. cerevisiae which produce UQ6 (wild type BY4741 and ∆coq1::pYES + COQ1) and UQ9
(∆coq1::pYES + At2g34630) [21]. Growth levels were observed in the presence and absence of 50–400 µM
farnesol (Figures 3 and 4). The two sets of experiments differ primarily in the degree of aeration
achieved. Figure 3 describes high aeration growth, 50 mL of YPD in 250 mL Erlenmeyer flasks shaking
continuously at 225 rpm, whereas Figure 4 describes low aeration growth, 0.2 mL of YPD per well in
96-well plates shaken for one min every 10 min. The 96-well plate format is technically advantageous
for measuring the growth of triplicate samples at 10 min intervals over 25 h while using minimal
amounts of farnesol. Additionally, the lower aeration shifts cellular metabolism towards a greater
reliance on fermentation, allowing us to confirm our expectation that farnesol inhibits respiration [6,10]
but not fermentation [27].
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Figure 2. Ubiquinone analysis in physiologically distinct C. albicans morphological types. The analysis
was undertaken by high-performance liquid chromatography (HPLC) in diode array detection (DAD)
mode using UQ10 as the internal standard (IS) [21]. (a) Representative histogram from ubiquinone
profile of C. albicans cells grown in synthetic (glucose-salts-biotin, GSB) medium. (b) Quantification
of ubiquinones as detected by HPLC-DAD. Trace indicates that the ubiquinone detected was below
the sensitivity limit of 0.1 pmol unit−1 OD600 nm. * Glucose-proline-phosphate (GPP) medium is
supplemented with N-acetylglucosamine as an inducer of hyphal growth. GPD is the defined medium
developed by Dumitru et al. [27] for anaerobic growth of C. albicans. Data are means ± standard
deviation (SD) of duplicate measurements.
Our high aeration results in YPD (Figure 3) showed 3–4 fold increased resistance to farnesol
in the UQ9 producing strain compared with its UQ6 producing parent. This increased resistance
to 50 and 100 µM farnesol for the UQ9-producing strain was evident in both the higher cell yields
achieved (compare Figure 3b vs. Figure 3a) and the lower percentage of dead cells observed (compare
Figure 3d vs. Figure 3c). Very similar results were obtained when the two yeast strains were grown in
three defined, minimal growth media, namely glucose-salts-biotin (GSB), yeast nitrogen base (YNB),
and glucose-phosphate-proline (GPP). In each case the BY4741 parent (UQ6) grew poorly in 50 µM
farnesol and poorly (GSB) or not at all (YNB and GPP) in 100 µM farnesol whereas the UQ9-producing
strain grew equally as well with and without 50 µM farnesol and 50–70% as well with 100 µM farnesol
(data not shown).
Similar results were observed for experiments carried out in 96-well plates under low aeration
except that the yeast cells were less sensitive to farnesol. In this case the UQ6 yeasts were inhibited only
slightly by 50 µM farnesol (Figure 4B) and the cell yield achieved by UQ6 yeasts in 100 µM farnesol
(Figure 4B) was 60% of the UQ9 yield (Figure 4C). These results are consistent with the low aeration
conditions shifting cellular metabolism from respiration to fermentation. They reinforce the view that
farnesol itself is not toxic to yeast cells, but instead it is the ROS generated by farnesol’s interaction with
respiring mitochondria which is toxic. Taken together these results agree with those of Okada et al. [32]
that under most growth conditions the length of the UQ tail makes very little difference but in the
presence of farnesol (Figures 3 and 4) it makes a substantial difference.
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3.3. Intracellular Reactive Oxygen Species (ROS) Accumulation Decreased with UQ9
Farnesol promotes generation of ROS, which subsequently inhibits growth in yeasts [10].
We examined the effect of lon er isoprenoid chains on ROS production induced by farnesol. Intracellular
ROS was measured via oxidation of the ROS-specific dye DHR123 to fluorescent rhodamine123.
As shown in Figure 5, S. cerevisiae produces less ROS with UQ9 as the major electron carrier than
with UQ6, in a dose-dependent manner increasing from 0 to 200 or 400 µM farnesol. Farnesol
concentrations of 200 and 400 µM are both well above the minimal inhibitory concentration value for
wild type S. cerevisiae and thus the similar fold increases observed for BY4741 (Figure 5) likely reflect
the maximum capacity for mostly dead cells. These experiments used H2O2 (10 mM) as the positive
control and, is lethal concentration, the UQ9 containing train (∆coq1::pYES + At2g34630) also
produced si nificantly less ROS than th wild type. This observation could be due to a more rapid
protective response to H2O2 in the presence of the more firmly embedded UQ or to the impact of a still
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to be discovered protective mechanism whereby UQ9 prevents or retards cell death in the presence of
an otherwise lethal concentration of H2O2. Our findings indicate that intracellular ROS accumulation
decreased with the presence of a longer isoprenoid chain in UQ.
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3.4. Respiratory Rate Remains Unchanged Regardless of UQ Isoprenologue
The replacement of UQ6 with UQ9 leads to greater farnesol resistance and less intracellular
ROS. These changes could be due to ubiquinone’s structural role in mitochondria or they could be
a secondary consequence of the UQ9-containing cells having less efficient respiration or a shift in
metabolism towards more fermentation and less respiration. Therefore, we compared S. cerevisiae
BY4741 and ∆coq1::pYES + At2g34630 and found that their respiration rates were 4.27 ± 0.30 and
4.02 ± 1.29% O2/min/OD600, with UQ6 and UQ9, respectively. This equivalence in mitochondrial
function suggests that the farnesol resistance observed is not due to slow or differential respiratory
rates. These results were expected because Okada et al. [32] found that even though S. cerevisiae prefers
UQ6, it could grow well with all UQ chain lengths between 5 and 10. In SC minimal medium containing
glycerol, the maximum growth rates with UQ8 and UQ9 were only slightly less than with UQ6 [32].
3.5. Oxidative Sensitivity and Osmotolerance in UQ6 vs. UQ9
We also wished to distinguish whether the enhanced resistance to farnesol exhibited by the UQ9
containing yeasts is due to the UQ9 itself or to a secondary physiological change triggered by the
UQ9. Thus, we compared the yeasts for their oxidative and osmotolerance towards common stress
agents. We observed the growth effects on YPD agar in the presence of added H2O2, menadione,
and sodium chloride (Figure 6). ∆coq1::pYES is effectively a petite and as expected it did not grow
on glycerol/lactate plates (see Figure 4A of [21]). The wild type BY4741 and recombinant S. cerevisiae
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∆coq1::pYES + At2g34630 use UQ6 and UQ9, respectively. We did not observe any differential responses
to these stress agents based on their ubiquinone contents (Figure 6). A separate set of experiments
with and without the selective agent G418 showed virtually identical growth patterns, thus indicating
that plasmid loss was not a problem in this timeframe. We conclude that general oxidative tolerance
and osmotolerance are unaffected by ubiquinone type. This conclusion is consistent with reports that
UQ deficient mutants tolerate most types of oxidative stress [33].
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YPD +0.05% galactose agar plates containing the indicated salt or oxidant and photographed after 48 h
at 30 ◦C.
3.6. Catalase Assays
Catalase (Cat1p) is a key enzyme in protecting cells from oxidative stress. It detoxifies hydrogen
peroxide and other oxidants, thereby restoring redox homeostasis. Farnesol (50 µM) induces
dose-dependent increases in CAT1 expression in C. albicans [24] and therefore catalase activity should
be induced by farnesol stress. Accordingly, we compared the catalase activities in UQ9- and UQ6-
containing yeasts but we did not find any significant differences in basal catalase activity or catalase
induction capacity (Figure 7). We conclude that Cat1p activity is unaffected by ubiquinone type.
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4. Discussion
The fungal pathogen C. albicans exhibits a remarkably greater ability to withstand oxidative stress
than do the model yeasts S. cerevisiae and Schizosaccharomyces pombe [34,35]. The distinctive and
robust stress tolerance mechanisms in C. albicans coevolved with host niche-specificity in order to evade
the oxidative killing pressures exerted by hostile immune protective mechanisms [35–37]. However,
the greater stress tolerance of C. albicans cannot be attributed solely to transcriptional regulation
of stress responsive genes since the antioxidant genes (CAT1, GPX, SOD) and the ROS scavenging
systems (glutathione/glutaredoxin, thioredoxin) are equally upregulated in all yeasts [37–39]. Thus,
the remarkable tolerance to farnesol to C. albicans compared with S. cerevisiae suggests the evolution of
specific structural adaptations as well as the general antioxidant responses just described. Here we
have shown that the structural differences inherent in having membrane bound UQ9 rather than UQ6
provides a significant advantage in tolerating farnesol and the oxidative stress induced by farnesol.
The added protection provided by UQ9 appears to be specific for farnesol and due to the UQ9 itself,
i.e., it is not a secondary effect. These conclusions are based on the fact that the UQ6 and UQ9
cells had equivalent osmotolerance (to 1 M NaCl) and redox tolerance (to 5 mM H2O2 and 1 mM
menadione) (Figure 6). They also had equivalent levels of catalase activity (Figure 7) and preliminary
analysis showed that they had equivalent amounts of total and phosphorylated Hog1p both before
and after stress with 10 mM H2O2 or 50–100 µM farnesol (data not shown). These findings support
our suggestion that the UQ9 side chains have evolved as a structural adaptation to farnesol rather
than as a superior general stress mechanism. According to our findings, it is very unlikely that
transcriptional regulation of oxidative protection is affected by the type of endogenous UQ present.
Also identifying the contribution of UQ9 side chains to high farnesol resistance in C. albicans points to
polyprenyl diphosphate synthase (Coq1p) as a potential target to control the dimorphic pathogenicity
of this fungus.
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Farnesol’s interaction with the mitochondrial membrane is likely responsible for the increased
toxicity (Figure 3) and excess ROS production (Figure 5) associated with UQ6 yeasts. This connection
between farnesol, ROS, and mitochondrial respiration is consistent with prior reports that some petite
mutants of S. cerevisiae are farnesol resistant [10,15] while anaerobically grown C. albicans did not
produce farnesol and did not respond to exogenous farnesol at concentrations ranging from 0 to
1.2 mM [27]. Note that 1.2 mM farnesol represents the maximum solubility of farnesol in water [27].
The enhanced resistance to farnesol was also observed for S. cerevisiae ∆coq1::pYES strains (Figure 5).
This strain lacks a complete aerobic respiration and is unable to grow in media containing only
non-fermentable carbon sources such as glycerol, thus is considered as a petite.
Machida et al. [10] showed that for S. cerevisiae farnesol generated reactive oxygen species (ROS)
by interacting with the mitochondrial electron transport chain. Here we corroborate their findings
while providing the added suggestion that UQ release or solvent exposure is one of the mechanisms
for ROS formation. Okada et al. [32] produced mutants of S. cerevisiae which synthesized UQ with
chain lengths varying from UQ5 up to UQ10. These mutants had roughly equivalent growth rates
and respiration rates [32]. Although S. cerevisiae has frequently been used as a model for C. albicans,
it is primarily non-pathogenic and it lacks the diverse morphogenic forms as in C. albicans. Because
C. albicans uses farnesol as a virulence factor in pathogenesis [4,5], it would be interesting to make
similar mutants of C. albicans, forced to use isoprenoid chain lengths varying from UQ5 to UQ10,
and then compare their respective levels of pathogenicity in mouse models of disseminated candidiasis.
However, the construction of respiratory deficient mutants in C. albicans could be challenging because
respiratory deficiency is usually lethal in almost all species of Candida [40].
The wide distribution of UQs in membranes of Golgi, lysosomes, peroxisomes, and cell membranes
other than mitochondria suggests UQ may be involved in roles other than electron transfer as reviewed
by [41–43]. The antioxidant function of UQ is well studied in that it protects against lipid peroxidation
in the membrane [44]. All these mechanisms are attributable to the redox active benzoquinone ring
of UQ. However, the biological significance of the ubiquinone side chain length is reported only
intermittently and no molecular or signaling mechanisms have been suggested for those observations.
Okada et al. [32] proposed that the UQ chain length was determined by the membrane hydrophobicity
of an organism while Katsikas and Quinn [45] suggested that UQ chain length aids in the localization
of UQ within phospholipid bilayers with longer chain lengths permitting efficient transmembrane
movement of hydrogen atoms [45].
Most interestingly, E. coli was recently found to accumulate far greater levels of its native UQ8
(110-fold) in response to osmotic stress (750 mM NaCl) [46]. The extra UQ8 increased membrane
stability quite independent of its role in respiration or radical scavenging. Sévin and Sauer [46]
concluded that the osmoprotection provided by UQ8 was conveyed by the octaprenyl tail and not by
the benzoquinone moiety, and that only chains of sufficient length were able to provide osmotolerance.
They also suggested that UQn with n > 8 isoprenoid units could provide mechanical stabilization of
cellular membranes but no further mechanisms for this osmoprotection have yet been identified. Due to
the variety of environmental niches where E. coli can be found [47], this physical mechanism could be
another evolutionary adapted trait in these bacteria to increase their fitness in both host-associated
and non-host associated habitats [47]. With our observation of farnesol protection conferred by longer
UQ side chain length, we conclude that having different isoprenoid side chain lengths in different
organisms is another example of niche-adapted evolutionary mechanisms by which chemical diversity
is generated in nature in order to provide a selective advantage. The importance of farnesol as a
virulence factor for C. albicans is such that using UQ9 is just one of the structural adaptations this
successful pathogen has made. Another possible adaptation is the pressure farnesol provides for
maintaining C. albicans as a diploid rather than as a haploid [48]. In addition to acting as a virulence
factor [4,5] and signaling molecule [2,3], farnesol has some detergent-like activity. Another example
of the complexity of cellular adaptations to detergents has been studied in enteric bacteria growing
in the presence of 5–10% sodium dodecyl sulfate (SDS). For Enterobacter cloacae and E. coli, their
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structural adaptations to SDS occur in at least five subcellular locations [49,50]. Moving progressively
inwards, these were (i) a negatively charged capsule provided by the presence of colanic acid [49];
(ii) the outer membrane as a necessary barrier; (iii) synthesis of negatively charged membrane-derived
oligosaccharides (MDOs) in the periplasm [50]; (iv) the cytoplasmic membrane as the site of efflux
pumps able to extrude SDS; and (v) the cytoplasm itself in the form of the ClpP, ClpX, and ClpB
proteases necessary to recycle proteins which have been damaged by the SDS [49]. Thus, SDS resistance
in enteric bacteria is a cooperative effort with contributions by five different cellular compartments.
We do not expect farnesol resistance in C. albicans to be as complicated but the present study is the
first step in finding out how farnesol resistance is achieved. Switching from UQ7 to UQ9 is a likely
adaptation made by C. albicans and C. dubliniensis to allow farnesol production.
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